To enact section 5.2540 of the Revised Code to designate March 20th as "Ameloblastoma Awareness Day."
Summary
SB 27 is a simple commemorative measure that designates March 20 as "Ameloblastoma Awareness Day" in Ohio. The bill adds a new section to the Revised Code establishing the annual observance, but it does not create a regulatory program, mandate state spending, or alter medical treatment rules. Its purpose is primarily to recognize and raise public awareness of ameloblastoma, a rare jaw tumor, and to encourage education about the condition.
Because the bill is limited to a calendar designation, its legal impact on state law is narrow. It enacts section 5.2540 of the Revised Code and adds March 20 to Ohio’s list of officially recognized awareness days, but it does not impose duties on agencies, employers, schools, or health care providers. The practical effect is symbolic: it gives advocates, patients, and medical organizations an official date to use for outreach and awareness efforts.
The available voting history suggests broad bipartisan support and little controversy. The bill passed the Senate committee 6-0, the Senate 32-0, the House committee 12-0, and the House 92-0, indicating unanimous or near-unanimous approval at each stage. No committee transcripts were provided, but the recorded votes show the measure was treated as a noncontroversial recognition bill.
There is little evidence of substantive opposition in the record. Any discussion would likely have centered on the appropriateness of creating another awareness day and the value of highlighting a rare disease, rather than on policy tradeoffs or fiscal concerns. The absence of recorded dissent suggests the main point of agreement was that the designation could help public education and support affected patients and families.
Impact
SB 27 amends the Revised Code by enacting section 5.2540 to formally designate March 20 as Ameloblastoma Awareness Day. The bill has no apparent fiscal or regulatory effect and does not change health care coverage, licensing, or treatment requirements. Its impact is limited to state recognition of a disease-awareness observance that may be used by advocates, medical professionals, and public health organizations for outreach and education.
Sentiment
The sentiment around SB 27 appears strongly favorable and noncontroversial. It advanced through both chambers with unanimous votes, including 6-0 in Senate committee, 32-0 in the Senate, 12-0 in House committee, and 92-0 in the House. That voting pattern indicates broad bipartisan support and a consensus that the bill is a harmless commemorative measure.
Contention
No significant contention is evident in the available record. The bill’s narrow scope likely limited debate to whether a state awareness day is useful and whether ameloblastoma merits special recognition. Because there were no recorded dissenting votes or committee objections, any concerns would have been minor and procedural rather than substantive, with no identifiable opposing faction in the materials provided.
To amend sections 3505.01 and 3505.10 of the Revised Code to modify the deadline for a political party to certify its nominees for President and Vice-President to the Secretary of State.
To amend sections 3517.12, 3517.13, and 3517.155 of the Revised Code to modify the Campaign Finance Law regarding foreign nationals and statewide initiatives and referenda and to declare an emergency.
To amend sections 3517.12, 3517.13, and 3517.155 of the Revised Code to modify the Campaign Finance Law regarding foreign nationals and statewide initiatives and referenda and to declare an emergency.
To delay the deadline for a major political party to certify its presidential and vice presidential candidates to the Secretary of State for the 2024 general election.